August 22, 2025

Tyra Biosciences, Inc. (TYRA): Analyst Consensus Unveils a 157% Potential Upside

Investors seeking opportunities in the biotechnology sector may find Tyra Biosciences, Inc. (NASDAQ: TYRA) an intriguing prospect. With its focus on precision medicines targeting fibroblast growth factor receptor (FGFR) biology,..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring a Potential 500% Upside in Biotechnology

Investors eyeing the biotechnology sector may find Humacyte, Inc. (NASDAQ: HUMA) an intriguing proposition, especially with a potential upside of 500.65% as indicated by analyst target prices. As of recent..

Akso Health Group (AHG) Stock Analysis: Navigating a 415.8% Revenue Growth Surge

Akso Health Group (NASDAQ: AHG), a key player in China’s burgeoning healthcare sector, is turning heads with its remarkable 415.8% revenue growth. Despite the lack of traditional valuation metrics like..

Inventiva S.A. (IVA) Stock Analysis: Exploring a 155.76% Potential Upside for Investors

Investors looking for opportunities in the biotechnology sector may find Inventiva S.A. – American Depositary Shares (IVA) an intriguing prospect, with a notable potential upside of 155.76%. Headquartered in Daix,..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a 179.97% Upside in the Biotech Sector

Upstream Bio, Inc. (NASDAQ: UPB) is making waves in the biotechnology sector, capturing the attention of investors with its promising potential upside of 179.97%. This clinical-stage biotech company, headquartered in..

Dianthus Therapeutics (DNTH) Stock Analysis: Strong Buy Ratings and 122% Potential Upside

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is capturing significant attention within the biotechnology sector, an industry known for its groundbreaking innovations and high-stakes ventures. As a clinical-stage biotechnology company headquartered in..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a Potential 213.90% Upside in Biotechnology

Investors looking for promising opportunities in the biotechnology sector may find Tectonic Therapeutic, Inc. (NASDAQ: TECX) an intriguing prospect. With a current market capitalization of $475.19 million, this Watertown, Massachusetts-based..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: An 18.58% Potential Upside for Investors in the Biotech Sector

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is capturing the attention of investors with an attractive potential upside of 18.58%. As a commercial-stage biopharmaceutical company, Xeris is strategically positioned in the..

Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 23.69% Potential Upside in the Healthcare Sector

Owens & Minor, Inc. (NYSE: OMI) operates within the healthcare sector, specifically in the medical distribution industry, offering an array of products and services critical to healthcare providers and patients..

Semler Scientific, Inc. (SMLR) Stock Analysis: Exploring a Potential 183.5% Upside

Semler Scientific, Inc. (NASDAQ: SMLR), a notable player in the healthcare sector, specializes in medical devices, with a focus on enhancing the efficiency and clinical effectiveness of healthcare providers in..

Autolus Therapeutics plc (AUTL) Stock Analysis: A Promising Biotech with 449.84% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL) is a burgeoning name in the biotechnology sector, primarily known for its innovative work in T cell therapies aimed at combating cancer and autoimmune diseases...

CeriBell, Inc. (CBLL) Stock Analysis: Unpacking the 156.85% Potential Upside

CeriBell, Inc. (CBLL), a burgeoning player in the healthcare sector, is capturing significant investor attention due to its promising potential upside of 156.85%. Specializing in medical devices, CeriBell is revolutionizing..

ATAI Life Sciences N.V. (ATAI) Stock Analysis: Unveiling a 157% Potential Upside in the Biotech Sector

ATAI Life Sciences N.V. (NASDAQ: ATAI), a Germany-based biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to mental health treatments. With a market capitalization of..

Orthofix Medical Inc. (OFIX) Stock Analysis: A Closer Look at its 54.98% Potential Upside

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector specializing in medical devices, stands out with a remarkable potential upside of 54.98%. This potential increase, based on..

Sage Therapeutics, Inc. (SAGE) Stock Analysis: Navigating the Challenges and Opportunities in the Biotech Landscape

Sage Therapeutics, Inc. (NASDAQ: SAGE) stands at a critical juncture within the competitive biotechnology sector. The company, headquartered in Cambridge, Massachusetts, is dedicated to developing innovative brain health medicines. Notably,..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Unlocking an 88.96% Upside Potential in Biotechnology

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical stage biopharmaceutical company based in South San Francisco, is emerging as a compelling player in the biotechnology sector. With a focus on developing..

Tourmaline Bio, Inc. (TRML) Stock Analysis: A Biotech Gem with 143.71% Potential Upside

Tourmaline Bio, Inc. (NASDAQ: TRML), a burgeoning player in the biotechnology sector, is captivating investor interest with its promising pipeline and remarkable growth potential. As a clinical-stage biotech firm, Tourmaline..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating a 15% Potential Upside in the Medical Devices Sector

As the healthcare sector continues to evolve with innovative solutions, Treace Medical Concepts, Inc. (NASDAQ: TMCI) stands out with its specialized focus on medical devices. With a market capitalization of..

Trevi Therapeutics, Inc. (TRVI) Investor Outlook: A Biotech Stock with 175% Upside Potential

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company based in New Haven, Connecticut, is capturing the attention of investors in the biotechnology sector. With a mission to develop innovative..

RxSight, Inc. (RXST) Stock Analysis: Evaluating the Potential in a Challenging Market

RxSight, Inc. (NASDAQ: RXST) is a medical device company at the forefront of innovation in the healthcare sector. With a focus on light adjustable intraocular lenses (LAL) for cataract surgery,..

Search

Funds

August 22, 2025

Search

Funds

August 22, 2025

FTSE 100

Funds